15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims/hypothesis

          South Asians have a two- to fivefold higher risk of developing type 2 diabetes than those of white European descent. Greater central adiposity and storage of fat in deeper or ectopic depots are potential contributing mechanisms. We collated existing and new data on the amount of subcutaneous (SAT), visceral (VAT) and liver fat in adults of South Asian and white European descent to provide a robust assessment of potential ethnic differences in these factors.

          Methods

          We performed a systematic review of the Embase and PubMed databases from inception to August 2021. Unpublished imaging data were also included. The weighted standardised mean difference (SMD) for each adiposity measure was estimated using random-effects models. The quality of the studies was assessed using the ROBINS-E tool for risk of bias and overall certainty of the evidence was assessed using the GRADE approach. The study was pre-registered with the OSF Registries ( https://osf.io/w5bf9).

          Results

          We summarised imaging data on SAT, VAT and liver fat from eight published and three previously unpublished datasets, including a total of 1156 South Asian and 2891 white European men, and 697 South Asian and 2271 white European women. Despite South Asian men having a mean BMI approximately 0.5–0.7 kg/m 2 lower than white European men (depending on the comparison), nine studies showed 0.34 SMD (95% CI 0.12, 0.55; I 2=83%) more SAT and seven studies showed 0.56 SMD (95% CI 0.14, 0.98; I 2=93%) more liver fat, but nine studies had similar VAT (−0.03 SMD; 95% CI −0.24, 0.19; I 2=85%) compared with their white European counterparts. South Asian women had an approximately 0.9 kg/m 2 lower BMI but 0.31 SMD (95% CI 0.14, 0.48; I 2=53%) more liver fat than their white European counterparts in five studies. Subcutaneous fat levels (0.03 SMD; 95% CI −0.17, 0.23; I 2=72%) and VAT levels (0.04 SMD; 95% CI −0.16, 0.24; I 2=71%) did not differ significantly between ethnic groups in eight studies of women.

          Conclusions/interpretation

          South Asian men and women appear to store more ectopic fat in the liver compared with their white European counterparts with similar BMI levels. Given the emerging understanding of the importance of liver fat in diabetes pathogenesis, these findings help explain the greater diabetes risks in South Asians.

          Funding

          There was no primary direct funding for undertaking the systematic review and meta-analysis.

          Graphical abstract

          Supplementary Information

          The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05803-5.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: not found
          • Article: not found

          Measuring inconsistency in meta-analyses.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

              Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and transparency of these reports, however, are not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (quality of reporting of meta-analysis) statement—a reporting guideline published in 1999—there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realising these issues, an international group that included experienced authors and methodologists developed PRISMA (preferred reporting items for systematic reviews and meta-analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this explanation and elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA statement, this document, and the associated website (www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.
                Bookmark

                Author and article information

                Contributors
                s.iliodromiti@qmul.ac.uk
                james.mclaren@glasgow.ac.uk
                Journal
                Diabetologia
                Diabetologia
                Diabetologia
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0012-186X
                1432-0428
                13 October 2022
                13 October 2022
                2023
                : 66
                : 1
                : 44-56
                Affiliations
                [1 ]GRID grid.4868.2, ISNI 0000 0001 2171 1133, Wolfson Institute of Population Health, , Queen Mary University of London, ; London, UK
                [2 ]GRID grid.8756.c, ISNI 0000 0001 2193 314X, School of Medicine, , University of Glasgow, ; Glasgow, UK
                [3 ]GRID grid.8756.c, ISNI 0000 0001 2193 314X, School of Cardiovascular and Metabolic Health, , University of Glasgow, ; Glasgow, UK
                [4 ]GRID grid.410513.2, ISNI 0000 0000 8800 7493, Worldwide Research Development and Medical, Pfizer, ; Cambridge, MA USA
                [5 ]AMRA Medical AB, Linköping, Sweden
                [6 ]GRID grid.5640.7, ISNI 0000 0001 2162 9922, Department of Medical and Health Sciences, , Linköping University, ; Linköping, Sweden
                [7 ]GRID grid.413301.4, ISNI 0000 0001 0523 9342, Department of Radiology, , Greater Glasgow and Clyde NHS, ; Glasgow, UK
                [8 ]GRID grid.422301.6, ISNI 0000 0004 0606 0717, Department of Clinical Physics and Bioengineering, , Beatson West of Scotland Cancer Centre, ; Glasgow, UK
                [9 ]GRID grid.413628.a, ISNI 0000 0004 0400 0454, Radiotherapy Physics, , Derriford Hospital, ; Plymouth, UK
                [10 ]GRID grid.189967.8, ISNI 0000 0001 0941 6502, Hubert Department of Global Health, Rollins School of Public Health, , Emory University, ; Atlanta, GA USA
                [11 ]GRID grid.266102.1, ISNI 0000 0001 2297 6811, Department of Medicine, , University of California San Francisco, ; San Francisco, CA USA
                Author information
                https://orcid.org/0000-0001-6453-6654
                https://orcid.org/0000-0003-4830-2676
                https://orcid.org/0000-0002-1604-2593
                https://orcid.org/0000-0003-3615-0986
                Article
                5803
                10.1007/s00125-022-05803-5
                9729139
                36224274
                d9eaf8d0-478e-438d-aefd-1c08f2595597
                © The Author(s) 2022

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 4 November 2021
                : 31 May 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MRC postdoctoral fellowship (MR/N015177/1).
                Categories
                Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2023

                Endocrinology & Diabetes
                abdominal,computed tomography,fat,liver,magnetic resonance imaging,meta-analysis,south asian,systematic review,visceral

                Comments

                Comment on this article